On the basis of a characteristic lesion of the endocervical mucosa in a woman who had taken contraceptives for 4 years, the authors review the problem of these alterations, also in light of their personal experience.
Get full access to this article
View all access options for this article.
References
1.
Candy AbellM.R.: Progestogen-induced adenomatous hyperplasia of the uterine cervix.J.A.M.A., 203: 85–88, 1968.
2.
CzemobilskyB.: Morphological changes in the cervix and vagina induced by combined hormonal medication. In: Dallenbach-HellwegG.: Functional Morphologic Changes in Female Sex Organs Induced by Exogenous Hormones, p. 191. Springer-Verlag, Berlin, 1980.
3.
Dallenbach-HellwegG.: Morphological changes induced in the human uterus and Falloppian tube by exogenous estrogens. In: Dallenbach-HellwegG.: Functional Morphologic Changes in Female Sex Organs Induced by Exogenous Hormones, p. 39. Springer-Verlag, Berlin, 1980.
4.
EppersonJ.W.W.HellmanL.GalvinG.BusbyT.: The morphological changes in the cervix during pregnancy, including intraepithelial carcinoma.Am. J. Obstet. Gynecol., 61: 50–61, 1951.
5.
FerenczjA.: Anatomy and histology of the cervix.In: Blaunstein A.: Pathology of Female Genital Tract, p. 102. Springer-Verlag, Berlin, 1977.
6.
FluhmannC.F.: A clinical and histopathological study of lesions of the cervix during pregnancy.Am. J. Obstet. Gynecol., 55: 133–147, 1948.
7.
GallS.A.BourgeoisH.MaguireR.: The morphologic effect of oral contraceptive agents on the cervix.J.A.M.A., 207: 2243–2247, 1969.
8.
GrahamC.E.Uterine cervical epithelium of fetal and immature human females in relation to estrogenic stimulation.Am. J. Obstet. Gynecol., 97: 1033–1040, 1967.
9.
HellmanL.M.RosenthalA.H.KistnerR.W.GordonR.: Some factors influencing the proliferation of the reserve cells in the human cervix.Am. J. Obstet. Gynecol., 67: 899–915, 1954.
10.
JohnsonL.D.: Carcinoma in situ in pregnancy.In: The Uterus, p. 382, Williams and Wilkins, Baltimore, 1973.
11.
KrausF.T.: The biology of carcinoma in situ and microinvasive carcinoma of the cervix.In: The Uterus, p. 348, Williams and Wilkins, Baltimore, 1973.
12.
KyriakosM.RichardL.KempsonR.L.KonikovN.F.: A clinical and pathologic study of endocervical lesions associated with oral contraceptives.Cancer, 22: 99–110, 1968.
13.
MaqueoM.AzuelaC.I.CalderonJ.J.GoldzieherJ.W.: Morphology of the cervix in women treated with synthetic progestins.Obstet. Gynecol., 96: 994–998, 1966.
14.
NicholsT.M.FilderH.K.: Microglandular hyperplasia in cervical cone biopsies taken for suspicious and positive cytology.Am. J. Clin. Pathol., 56: 424–429, 1971.
15.
SchaudeH.Dallenbach-HellwegG.SchlaferK.: Histologic changes of the cervix uteri following contraceptive use.In: Dallenbach-Hellweg: Functional Morphologic Changes in Female Sex Organs Induced by Exogenous Hormones, p. 191. Springer-Verlag, Berlin, 1980.
16.
SiiteriP.K.MacDonaldP.C.: Role of extraglandular estrogens in human endocrinology. In: GeigerS.R.AstwoodE.B. and GreepR.O. (eds.): Handbook of Physiology. Sect. 7,2. p. 615. N.Y. Am. Phys. Soc., 1973.
17.
SiiteriP.K.: Steroid hormones and endometrial cancer.Cancer Res., 38: 4360–4366, 1978.
18.
TaylorH.B.IreyN.NorrisJ.H.: Atypical endocervical hyperplasia in women taking oral contraceptives.J.A.M.A., 202: 185–187, 1967.